Medtronic Cardiac Rhythm and Heart Failure
278
6
11
231
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 35/100
12.2%
34 terminated/withdrawn out of 278 trials
87.2%
+0.7% vs industry average
13%
37 trials in Phase 3/4
63%
146 of 231 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (278)
Evolution of Intracardiac Electrograms Recorded by Left Bundle Branch Pacing Lead in Patients With ICD or CRT-D
Role: lead
ELEVATE-HFpEF Clinical Study
Role: lead
The CT-verified Data Collection Study to Investigate the Correlation Between the Leadless Pacemaker Tip Location and Echo, ECG
Role: lead
Characterizing Outcomes and Real-World Experience of Cardiac Physiologic Pacing (The CORE-CPP Study)
Role: lead
Advancing Clinical Heart Failure Outcomes Leveraging Defibrillation Lead Implant System for Left Bundle Branch Area Pacing
Role: lead
Fast Induced Remodeling in Heart Failure With Preserved Ejection Fraction
Role: lead
Neurovascular Product Surveillance Registry
Role: collaborator
Management of Device Detected AT and Impact of Device Treatment Algorithms on Atrial Fibrillation
Role: lead
The Ailliance Post-Market Clinical Study
Role: collaborator
PLASMA Mexico (PLASMA Mexico)
Role: lead
DelIVery for Pulmonary Arterial Hypertension (PAH) & Continued Support Study
Role: lead
China 3T MRI Study
Role: lead
Algorithm Using LINQ Sensors for Evaluation And Treatment of Heart Failure
Role: lead
Cardiac Implantable Electronic Device (CIED) Research Study
Role: lead
Lead EvaluAtion for Defibrillation and Reliability (LEADR) / Lead Evaluation for Defibrillation and Reliability in Left Bundle Branch Area Pacing (LEADR LBBAP)
Role: lead
Bolt CSP-M Holter Study
Role: lead
A Clinical Trial to Evaluate the HeartWare MVAD® System (MVAdvantage)
Role: lead
EMRI SureScan™ Clinical Study
Role: lead
ExtraVascular Implantable Cardioverter Defibrillator (EV ICD) Japan Study
Role: lead
Destination Therapy Post Approval Study
Role: lead